Sanket Koul, Shreya Nandi

Stories by Sanket Koul, Shreya Nandi

How India Is Rewriting Its FTA Playbook

How India Is Rewriting Its FTA Playbook

Rediff.com   5 days ago

India has been on an FTA-signing spree of late. Since 2021, it has signed eight trade agreements, three of which -- with the UK, Oman and New Zealand -- were finalised in 2025 alone.

Centre mandates blue strip on antimicrobial drugs to curb overuse

Centre mandates blue strip on antimicrobial drugs to curb overuse

Rediff.com   24 Jan 2026

The Union health ministry has issued draft rules to mandate a blue vertical strip on all antimicrobial drug labels, aiming to rein in over-the-counter misuse and tackle India's growing antimicrobial resistance (AMR) problem.

Dr Reddy's profit down 14% on low Lenalidomide US sales

Dr Reddy's profit down 14% on low Lenalidomide US sales

Rediff.com   22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y) drop in consolidated net profit to Rs 1,210 crore in the December quarter of FY 2025-26 (Q3FY26) on low sales of cancer drug Lenalidomide in the North American market. The firm's revenue from operations grew to Rs 8,727 crore in Q3FY26, a 4.4 per cent Y-o-Y increase from Rs 8,357 crore recorded for the same quarter last year.

NEET-PG Cutoff Cut Sparks Merit Debate

NEET-PG Cutoff Cut Sparks Merit Debate

Rediff.com   22 Jan 2026

'To fill these seats, eligibility is being diluted. We are compromising merit and producing degree holders instead of good doctors.'

Venezuela Turmoil Unlikely To Rattle India's Trade

Venezuela Turmoil Unlikely To Rattle India's Trade

Rediff.com   12 Jan 2026

'The immediate impact for India will be very minimal as the share of Venezuela in our total overseas production is very low.'

500% US Tariff Threat Looms Over India

500% US Tariff Threat Looms Over India

Rediff.com   9 Jan 2026

A 500 per cent tariff would effectively shut out India's goods and services exports to the US.

Govt Bans Sale Of Oral Nimesulide

Govt Bans Sale Of Oral Nimesulide

Rediff.com   2 Jan 2026

The Union health ministry has banned the manufacture, sale and distribution of all oral formulations containing the popular painkiller nimesulide above 100 milligrams for human use, citing health risks.

Centre launches Rs 4,531 cr mkt access support scheme

Centre launches Rs 4,531 cr mkt access support scheme

Rediff.com   1 Jan 2026

The government on Wednesday launched Rs 4,531 crore market access support (MAS) intervention scheme for a six-year period (FY26-31) to improve global reach, visibility and competitiveness of Indian exporters through 'structured and outcome-oriented' interventions.

Centre Proposes Stricter Cough Syrup Rules

Centre Proposes Stricter Cough Syrup Rules

Rediff.com   1 Jan 2026

Following the death of 22 children due to consumption of contaminated cough syrups in Madhya Pradesh three months ago, the Union health ministry has proposed amendments in the country's drug rules to ensure a tougher criterion for their over-the-counter (OTC) sales in India.

India-US to resume trade talks in January

India-US to resume trade talks in January

Rediff.com   31 Dec 2025

Talks on the proposed trade deal between India and the United States will resume after the year-end holidays, coinciding with Sergio Gor -- a close aide of American President Donald Trump -- taking charge as the US Ambassador to India in early January, according to a person privy to the development.

Why non- NCR developers are flocking to Gurugram

Why non- NCR developers are flocking to Gurugram

Rediff.com   30 Dec 2025

Gurugram, already established as the corporate hub of Delhi-NCR, is increasingly attracting developers from outside the region, drawn by robust end-user demand, premium pricing, and emerging development opportunities.

Weightloss Drugs Hit 1,000 Crore Mark

Weightloss Drugs Hit 1,000 Crore Mark

Rediff.com   22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'

Malaysia's IHH plans India expansion after Fortis open offer

Malaysia's IHH plans India expansion after Fortis open offer

Rediff.com   16 Dec 2025

After completion of its mandatory tender offer in Fortis Healthcare and Fortis Malar Hospitals, Malaysian health care giant IHH Healthcare is aiming to add 2,000 beds in a bid to double down on value creation in India. IHH, which is Asia's largest multinational private healthcare provider, currently has over 5,000 beds across a combined network of 35 hospitals and 11 states.

One-Regulator Education Bill Sent To Panel

One-Regulator Education Bill Sent To Panel

Rediff.com   16 Dec 2025

'It interferes in administrative matters of institutions, robbing them of their independence in day-to-day affairs and appointments.'

'14+ Anti-Obesity Drugs In The Pipeline'

'14+ Anti-Obesity Drugs In The Pipeline'

Rediff.com   13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

Mexico imposes up to 50% tariff on imports from India and China

Mexico imposes up to 50% tariff on imports from India and China

Rediff.com   12 Dec 2025

Mexico on Thursday imposed a tariff of up to 50 per cent on imports from its non-preferential trade partners, including India, a move that might hit New Delhi's annual $5.75 billion shipments to its third-largest car export market.

20% Shopping Centres Are Ghost Malls

20% Shopping Centres Are Ghost Malls

Rediff.com   12 Dec 2025

Ghost malls have a vacancy rate of over 50 per cent.

Indian Student Numbers Surge at UCL

Indian Student Numbers Surge at UCL

Rediff.com   10 Dec 2025

University College London has recorded a 19 per cent and 26 per cent rise in undergraduate and postgraduate students from India for the 2026 term, indicating a preference for the UK over the US at a time when Indian students are facing visa uncertainties in US-based institutions.

Pan masala cess to boost public health, security

Pan masala cess to boost public health, security

Rediff.com   8 Dec 2025

Experts said that earmarking of funds for public health at par with national security indicates a key policy shift.

IIT Students Get 90 Lakh To 3 Cr Offers!

IIT Students Get 90 Lakh To 3 Cr Offers!

Rediff.com   4 Dec 2025

Several IITs have been pushing for a diversification of job profiles as roles move beyond just tech companies and start-ups, particularly with the advent of AI.